Services
Data Cards
Blogs
Resources
Contact Us
Get 50 Free Samples Contact Us

Rheumatology Email List | 28,940 Verified Contacts | SparkDBi

A rheumatology email list is a verified database of licensed rheumatologists, pediatric rheumatologists, rheumatology nurse practitioners, and rheumatology physician assistants, built from conference and CME partnerships, state and national professional association directories, healthcare publication networks, and B2B2C matching and verification programs. SparkDBi maintains 28,940 verified US rheumatology contacts across 8 subspecialties.

SparkDBi Data Research Team Updated June 2026 10 min read
28,940Verified Contacts
8Subspecialties
91.5%Email Verified
MonthlyRefresh Cycle

Trusted by 2,600+ world-class brands and organizations

Eli Lilly NTT DATA Oracle SurveyMonkey Thermo Fisher Scientific WPP American Express

SparkDBi maintains a verified rheumatology email list covering 28,940 rheumatologists, pediatric rheumatologists, rheumatology nurse practitioners, and clinical immunologists across the United States. Every contact is sourced from conference and CME partnerships, state licensing records, and professional association directories, then validated through email inbox verification, phone validation, and physical address confirmation. The database refreshes monthly.

Rheumatology is the central prescribing specialty for biologic and targeted synthetic DMARDs, the highest-value drug class in the autoimmune space. With the TNF inhibitor market now joined by IL-17 and IL-23 inhibitors, JAK inhibitors, and an expanding biosimilar landscape, reaching rheumatologists at the right practice type and subspecialty has become essential for life sciences commercial teams.


Conditions, Drugs, and Devices in Rheumatology

Rheumatoid arthritis (RA) is the highest-volume prescribing category. Methotrexate remains the anchor conventional DMARD, with biologics added in treatment-escalation protocols. TNF inhibitors (adalimumab, etanercept, infliximab, certolizumab pegol, golimumab) are the most widely prescribed biologics. IL-6 inhibitors (tocilizumab, sarilumab) and CTLA4-Ig (abatacept) address patients who fail TNF therapy. JAK inhibitors (tofacitinib, baricitinib, upadacitinib, filgotinib) have added an oral small-molecule option that competes directly with biologics in moderate-to-severe RA.

Psoriatic arthritis (PsA) and ankylosing spondylitis (AS) represent the second-largest prescribing category. IL-17 inhibitors (secukinumab, ixekizumab, bimekizumab) and IL-23 inhibitors (guselkumab, risankizumab) have emerged as first-line biologics in PsA, while TNF inhibitors and IL-17 inhibitors dominate AS. The PsA and AS markets are actively contested across all major biologic classes, requiring precise rheumatologist outreach separated from general RA targeting.

Systemic lupus erythematosus (SLE) is a high-complexity autoimmune condition with a limited treatment landscape that has expanded recently with belimumab (Benlysta), anifrolumab (Saphnelo), and voclosporin (Lupkynis) for lupus nephritis. SLE outreach requires filtering rheumatologists who manage complex connective tissue disease.

Gout is managed by rheumatologists for treatment-refractory cases requiring febuxostat, allopurinol titration, or pegloticase (Krystexxa) for chronic refractory tophaceous gout. Osteoporosis is treated by rheumatologists using bisphosphonates, denosumab (Prolia/Xgeva), romosozumab (Evenity), and teriparatide (Forteo) for patients with fragility fractures or high fracture risk.

Ultrasound devices for musculoskeletal imaging have been adopted by a growing segment of rheumatologists for joint assessment and guided injection. Point-of-care ultrasound (POCUS) manufacturers and distributors target rheumatologists at academic and large group practice settings.


Who Uses the Rheumatology Email List

Pharmaceutical companies with biologic DMARDs and JAK inhibitors represent the largest buyer segment. With more than 15 approved biologics competing in RA, PsA, and AS, companies running switch programs, adherence support, and new indication launches depend on precise rheumatologist segmentation to avoid wasteful broad-reach outreach.

Biosimilar companies are an expanding buyer. Adalimumab biosimilars (Hadlima, Hyrimoz, Cyltezo, Yusimry, Simlandi) have created an intensely competitive landscape requiring direct rheumatologist outreach to support formulary positioning and prescriber education. Etanercept, infliximab, and abatacept biosimilars have added further pressure on originator brands.

Medical device companies with musculoskeletal ultrasound systems, infusion chair and pump suppliers, and clinical software companies targeting rheumatology practices also use the list. CME providers producing rheumatology continuing education content use it for program promotion and faculty recruitment.

BuyerHow They Use the Rheumatology List
Pharma - biologic DMARDRheumatologist outreach for RA biologic step-up protocols, targeting prescribers managing patients who have failed methotrexate monotherapy
Biosimilar companyDirect rheumatologist outreach for adalimumab biosimilar education and formulary positioning against originator adalimumab programs
Pharma - JAK inhibitorRheumatologist segmentation by practice type for oral JAK inhibitor programs in RA, PsA, and AS, filtered by prior biologic prescribing patterns
Pharma - SLE programRheumatologist list filtered for connective tissue disease and lupus subspecialty, targeting academic and large group practice settings
Device - POCUSRheumatology group practice and academic department outreach for point-of-care musculoskeletal ultrasound adoption programs

Request Rheumatology Contact Data

Subspecialty filters, practice setting, sample records available


Rheumatology Subspecialties and Verified Contacts

The SparkDBi rheumatology database covers 8 subspecialty segments. All segments are available individually or in combination with subspecialty flags.

SubspecialtyProvider TypeContacts
RheumatologistPhysician18,200
Rheumatology Nurse PractitionerNurse Practitioner3,150
Rheumatology Physician AssistantPhysician Assistant2,080
Pediatric RheumatologistPhysician1,490
Clinical ImmunologistPhysician1,320
Osteoporosis and Metabolic Bone Disease SpecialistPhysician980
Musculoskeletal RadiologistPhysician850
Rheumatology Clinical PharmacistPharmacist870

All 8 subspecialty segments by verified contact count. Total: 28,940.


Geographic Coverage

The US rheumatology database covers all 50 states. Highest concentrations are in California, New York, Texas, and Florida, reflecting population density and the locations of major academic rheumatology programs and large group practices.

Top 10 US States - Verified Rheumatology Contacts
StateVerified Contacts
California4,180
New York3,420
Texas2,650
Florida2,310
Pennsylvania1,740
Ohio1,420
Illinois1,290
Massachusetts1,180
North Carolina980
Michigan870

International rheumatology data is available for the UK, Germany, France, Canada, and Australia. Contact SparkDBi for current counts by country.


Top Rheumatology Centers

Academic medical centers and large group practices represent the highest-value rheumatology outreach targets for biologics companies and medical device programs. SparkDBi can filter by institution type, practice size, and academic affiliation.

Top US Rheumatology Programs by Research and Clinical Volume
RankInstitutionLocation
1Hospital for Special SurgeryNew York, NY
2Mayo ClinicRochester, MN
3Cleveland ClinicCleveland, OH
4Johns Hopkins HospitalBaltimore, MD
5Brigham and Women's HospitalBoston, MA
6University of California San FranciscoSan Francisco, CA
7Duke University Medical CenterDurham, NC
8University of MichiganAnn Arbor, MI
9Washington University in St. LouisSt. Louis, MO
10University of Alabama BirminghamBirmingham, AL

How SparkDBi Sources and Verifies HCP Data

SparkDBi builds its HCP contact database from multiple vetted channels. Primary sources include conference attendance and CME event participation records from healthcare education partners, member directories from state and national professional associations, subscriber and contributor lists from healthcare publication networks, and B2B2C data matching and verification partnerships.

Publicly available sources including CMS and NPPES records are used as a cross-reference and comparison tool only. They are not a primary data source. CMS and NPPES data is frequently stale or out of date for direct contact purposes. SparkDBi treats it as one reference point among many rather than a source of record.

Verification runs across three dimensions. Email inbox verification connects directly to the receiving mail server and confirms the specific mailbox accepts incoming messages, without sending a message. Phone validation confirms work phone numbers are active and matched to the provider record. Physical address validation covers both work practice addresses and home addresses, with records that fail validation removed and replaced in the next monthly refresh cycle.


NPI Taxonomy Codes for Rheumatology

CMS NPI taxonomy codes for reference. These are useful when specifying subspecialty requirements or independently verifying provider credentials.

Taxonomy CodeClassification
207RR0500XRheumatology
2080P0006XPediatrics - Rheumatology
207RI0001XClinical and Laboratory Immunology (Internal Medicine)
363L00000XNurse Practitioner (Rheumatology setting)
363A00000XPhysician Assistant (Rheumatology setting)

Practice Setting Breakdown

Rheumatology is dominated by private group practice and academic medical centre settings. Approximately 55% of rheumatologists in the SparkDBi database practice in private group settings or multi-specialty group practices. The remaining 45% are in academic hospital systems, federally qualified health centres, or hospital-employed positions.

Private-practice rheumatologists have more direct formulary flexibility compared to hospital-employed rheumatologists, who operate under health system pharmacy and therapeutics committee constraints. SparkDBi can filter by practice setting to target the population most relevant for each campaign objective.


Deliverability

Rheumatologists in private group practice use practice-domain email, which typically shows strong inbox placement. Academic and hospital-employed rheumatologists use enterprise email environments with more aggressive filtering. SparkDBi flags enterprise vs independent email domains in delivered datasets so buyers can apply domain-specific send strategies.


Data Enrichment and Available Fields

For existing rheumatology contact lists, SparkDBi can append or verify: NPI numbers, subspecialty classifications, practice setting, email addresses, practice addresses, and license status. Match rates average 71% against the full database.

Full NameNPI NumberSubspecialtyNPI Taxonomy CodeEmail AddressPractice AddressCity / State / ZIPPhone (where available)Practice SettingLicense StateCell Phone (where available)Home AddressPersonal Email (where available)

Compliance

The SparkDBi rheumatology email list contains no patient data. All records are professional contact information for licensed rheumatology providers. The database is HIPAA-aligned, CAN-SPAM compliant, and CCPA-aware. Business Associate Agreements are available on request.


Frequently Asked Questions


Related HCP Email Lists and Services